The drugs for hormonal replacement therapy global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Drugs For Hormonal Replacement Therapy Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The drugs for hormonal replacement therapy market size has grown strongly in recent years. It will grow from $12.99 billion in 2023 to $13.77 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth in the historic period can be attributed to aging population, increasing awareness, lifestyle factors, regulatory approvals, market globalization.
The drugs for hormonal replacement therapy market size is expected to see strong growth in the next few years. It will grow to $16.82 billion in 2028 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to rising incidence of hormonal disorders, healthcare infrastructure, increasing health consciousness, patient education and empowerment. Major trends in the forecast period include technological advancements, personalized medicine, research and development, personalized hormone therapy, alternative delivery methods, combination therapies, telemedicine and telehealth, digital health solutions.
Order your report now for swift delivery @
Scope Of Drugs For Hormonal Replacement Therapy Market
The Business Research Company’s reports encompass a wide range of information, including:
- Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
- Drivers: Examination of the key factors propelling market growth.
- Trends: Identification of emerging trends and patterns shaping the market landscape.
- Key Segments: Breakdown of the market into its primary segments and their respective performance.
- Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
- Macro Economic Factors: Assessment of broader economic elements impacting the market.
Drugs For Hormonal Replacement Therapy Market Overview
Market Drivers –
The increasing population of aging and postmenopausal women is driving the drugs for hormonal replacement therapy market. Hormonal replacement therapy drugs such as estrogen, progesterone, and others are used to treat medical conditions caused by menopausal conditions. For instance, in February 2021, according to the United Nations Economic and Social Commission for Asia and the Pacific, a Thailand-based regional commission, over half of the people who are over 65 are women, making up over 9% of the total population. By 2050, this percentage is projected to nearly double to more than 18%. From 1.7% to 4.9% of the population, the proportion of people over 80 will almost treble, with women making up over 60% of this group. There are a number of factors that could make older women more vulnerable than older men. According to the European Menopause and Andropause Society (EMAS) report, women aged over 60 are expected to reach over 1 billion by 2050. In South Korea, the female population is expected to exceed the male population by 2060, out of which 59.6% of the female population is expected to suffer from postmenopausal symptoms. Thus, the growing female population suffering from menopausal symptoms and the aging population drive the growth of drugs for hormonal replacement therapy market
The drugs for hormonal replacement therapy market covered in this report is segmented –
1) By Therapy Type: Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Menopause, Other Applications
Sub- Segments
By Route of Administration: Oral, Parental, Other Route of Administration
Get an inside scoop of the drugs for hormonal replacement therapy market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=2575&type=smp
Regional Insights –
North America was the largest region in the drugs for hormonal replacement therapy market in 2023. The Middle East is expected to be the fastest-growing region in the drugs for hormonal replacement therapy market during the forecast period. The regions covered in the drugs for hormonal replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Key Companies –
Major companies operating in the drugs for hormonal replacement therapy market include Novartis AG, Bayer AG, Pfizer Inc., Novo Nordisk AS, Eli Lilly and Company, Abbott Laboratories, Mylan N.V., Merck & Co., Hisamitsu Pharmaceutical Co. Inc., Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche Ltd., Noven Pharmaceuticals Inc., Orion Pharma AB, Allergan Plc, QuatRx Pharmaceuticals, Wyeth Ltd., Amgen Inc., Genentech USA Inc., TherapeuticsMD Inc., Viatris Inc., AbbVie Inc., GlaxoSmithKline plc, Sanofi S.A., Johnson & Johnson Services Inc., AstraZeneca plc, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Takeda Pharmaceutical Company Limited
Table of Contents
- Executive Summary
- Drugs For Hormonal Replacement Therapy Market Characteristics
- Drugs For Hormonal Replacement Therapy Market Trends And Strategies
- Drugs For Hormonal Replacement Therapy Market – Macro Economic Scenario
- Global Drugs For Hormonal Replacement Therapy Market Size and Growth
…………..
- Key Mergers And Acquisitions In The Drugs For Hormonal Replacement Therapy Market
- Drugs For Hormonal Replacement Therapy Market Future Outlook and Potential Analysis
- Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Drugs For Hormonal Replacement Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
………….
Table 74: Novartis AG Financial Performance
Table 75: Bayer AG Financial Performance
Table 76: Pfizer Inc. Financial Performance
Table 77: Novo Nordisk AS Financial Performance
Table 78: Eli Lilly and Company Financial Performance
Read Related Reports:
https://goodprnews.com/aircraft-maintenance-repair-and-overhauling-services-market-size/
https://topprnews.com/anti-thyroid-drugs-market-share/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
